Liberia: Prevail Begins Clinical Research On Lassa Fever Study Vaccine
[FrontPageAfrica] Monrovia -- The Partnership for Research on Vaccines and Infectious Diseases in Liberia (PREVAIL), a joint Liberia-United States research partnership, has launched a Phase I clinical study to evaluate a candidate Lassa fever vaccine in adults of good health in Liberia.
Source: AllAfrica News: Health and Medicine - Category: African Health Source Type: news
More News: African Health | Infectious Diseases | Lassa Fever | Liberia Health | Partnerships | Study | USA Health | Vaccines